Issued Patents 2025
Showing 1–25 of 26 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12428391 | Dimethylsulfoximine derivative | Wenyuan Qian, Yonggang Liao, Changqing Wei, Zhengying Xi, Yao Xiao | 2025-09-30 |
| 12421269 | SGLT2/DPP4 inhibitor and application thereof | Qinghua Mao, Tao Yu, Lu Gan, Yi Li, Chengde Wu | 2025-09-23 |
| 12421236 | Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor | Charles Z. Ding | 2025-09-23 |
| 12415799 | Indazole-fused cyclic compound | Ke AN, Na Gao, Guoping HU, Jian Li, Deheng Sun | 2025-09-16 |
| 12410196 | Benzopyrimidine compounds and use thereof | Yang Zhang, Wentao Wu, Kaijun GENG, Jikui SUN, Yangyang Xu +1 more | 2025-09-09 |
| 12410155 | Salt form and crystal form of tetrahydrocyclohepta indazole compound | Ke AN | 2025-09-09 |
| 12398153 | Spiro compound serving as ERK inhibitor, and application thereof | Yi Li, Ning Liu, Tao Yu, Chengde Wu, Jian Li | 2025-08-26 |
| 12398138 | FGFR inhibitor compound in solid form and preparation method therefor | Zhifei Fu, Miaorong Luo, Jikui SUN, Yang Zhang, Jian Li | 2025-08-26 |
| 12378253 | Pyrrolopyrimidine compound as BTK inhibitor and use thereof | Yang Zhang, Wentao Wu, Kaijun GENG, Qiu LI, Jian Li | 2025-08-05 |
| 12378277 | SGLTS/DPP4 inhibitor and application thereof | Qinghua Mao, Tao Yu, Yi Li, Chengde Wu | 2025-08-05 |
| 12378241 | Pyridine derivative as FGFR and VEGFR dual inhibitors | Zhengxia Chen, Meibi Dai, Yang Zhang | 2025-08-05 |
| 12365686 | Compound as porcupine inhibitor and use thereof | Xiongbin XU, Yi Chen, Cailin WANG, Ru Feng, Wen Jiang +2 more | 2025-07-22 |
| 12358927 | IRAK4 inhibitor crystal and preparation method therefor | Yang Zhang, Jianfei Wang, Haizhong TAN, Yuhai Xing, Jian Li | 2025-07-15 |
| 12351587 | Bicyclic compound as RIP-1 kinase inhibitor and application thereof | Wei Wei, Peng Li, Haiying He | 2025-07-08 |
| 12351590 | Pyrrolopyrimidine compound and use thereof | Wenyuan Qian, Changqing Wei, Guoping HU, Jian Li | 2025-07-08 |
| 12338263 | Antibacterial aminoglycoside derivatives | Dongdong TANG, Zhigang Huang, Cheng LI, Charles Z. Ding | 2025-06-24 |
| 12325695 | 5-(4-pyridyloxy)pyrazole compounds serving as TGF-βR1 kinase inhibitor | Xiangyu FU, Charles Z. Ding, Lihong Hu | 2025-06-10 |
| 12325703 | Fused ring compound as FGFR and VEGFR dual inhibitor | Zhengxia Chen, Haizhong TAN, Yang Zhang, Jian Li | 2025-06-10 |
| 12319692 | Anti-influenza virus pyrimidine derivatives | Jian Xiong, Chaofeng Long, Jingjing Wang, Xiaoxin Chen, Kevin X. Chen +4 more | 2025-06-03 |
| 12310948 | Application of monocyclic β-lactam compound in pharmacy | Xiawei WEI, Charles Z. Ding, Jian Li, Yuquan Wei | 2025-05-27 |
| 12312347 | Azaindole derivative and use thereof as FGFR and C-Met inhibitor | Yang Zhang, Zhengxia Chen, Yikai Wang, Meibi Dai, Jie Li +2 more | 2025-05-27 |
| 12297197 | Pyrazolopyridine compound as RET inhibitor and application thereof | Jiansong Wang, Zhengxia Chen, Zhibo LUO, Meibi Dai, Yang Zhang +3 more | 2025-05-13 |
| 12291536 | Crystal form of Wee1 inhibitor compound and use thereof | Wenyuan Qian, Chundao Yang, Zhengwei Li, Jie Li, Jian Li | 2025-05-06 |
| 12258367 | Glucoside derivative that acts as SGLT1 inhibitor and application thereof | Yi Li, Tao Yu, Qinghua Mao, Chengde Wu | 2025-03-25 |
| 12240849 | Nitrogen-containing spiro derivative as RET inhibitor | Jiansong Wang, Zhifei Fu, Zhibo LUO, Miaorong Luo, Yang Zhang +6 more | 2025-03-04 |